Condition
Pleural Epithelioid Mesothelioma|Pleural Malignant Mesothelioma
Estimated Enrollment: 10
Age Group: 18 Years and older (Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Intervention Model: Single Group Assignment|Masking: Open Label|Primary Purpose: Treatment
Study ID Numbers: 15-000487|NCI-2015-01736|JCCCID552|P30CA016042
Study First Received: November 2, 2015
Last Updated: August 8, 2016
Estimated Primary Completion Date: January 2018
Primary Outcome Measures:
Ability to accrue sufficient patients to draw conclusions about endpoints in a timely and expedient manner|Incidence of acute and subacute toxicity defined as grade 4 or 5 adverse events as assessed by the National Cancer Institute (NCI) Common Terminology Criteria for Adverse Events (CTCAE) version 4.0|Incidence of chronic toxicity as assessed by the NCI CTCAE version 4.0|Disease Specific Survival (DSS)|Local Control (LC)|Overall Survival (OS)|pathologic Complete Response Rate (pCR)
Sponsors and Collaborators:
Jonsson Comprehensive Cancer Center|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT02672033
